| First Author | Luo F | Year | 2021 |
| Journal | Mol Metab | Volume | 53 |
| Pages | 101299 | PubMed ID | 34271222 |
| Mgi Jnum | J:330003 | Mgi Id | MGI:6818145 |
| Doi | 10.1016/j.molmet.2021.101299 | Citation | Luo F, et al. (2021) Missense variant in insulin receptor (Y1355H) segregates in family with fatty liver disease. Mol Metab 53:101299 |
| abstractText | A missense variant in the cytoplasmic domain of the insulin receptor (INSR) was identified by exome sequencing in affected members of a four-generation family with fatty liver disease (FLD). The variant (rs766457461, c.4063T>C, p.Y1355H) results in the substitution of histidine for a tyrosine that undergoes autophosphorylation in response to insulin stimulation in vitro. Because insulin promotes lipogenesis in hepatocytes, we hypothesized that the variant was causally linked to FLD in the family. To test this hypothesis, we used CRISPR/Cas9 technology to replace the corresponding tyrosine in mouse INSR with histidine (Y1345H). No significant differences were found in hepatic insulin signaling, as assessed by phosphorylation of INSR or AKT levels or in activation of the insulin-responsive transcription factor SREBP-1c. Glucose tolerance and hepatic triglyceride (TG) content in Insr(1345H/H) mice fed a chow diet or diets rich in fat, sucrose or fructose did not differ significantly from WT littermates. Thus, our studies in mice failed to support the notion that INSR (Y1355H) is causally related to FLD in the family or that phosphorylation of this residue alters hepatic TG metabolism. |
